EL
DFTX

EMFO LLC’s Definium Therapeutics DFTX Stock Holding History

EMFO LLC’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$2.16K Hold
300
– – ﹤0.01% 260
2024
Q1 		$2.82K Hold
300
– – ﹤0.01% 261
2023
Q4 		$1.1K Hold
300
– – ﹤0.01% 265
2023
Q3 		$939 Hold
300
– – ﹤0.01% 281
2023
Q2 		$1.07K Hold
300
– – ﹤0.01% 292
2023
Q1 		$951 Hold
300
– – ﹤0.01% 295
2022
Q4 		$660 Sell
300
-300
-50% -$833 ﹤0.01% 286
2022
Q3 		$2K Buy
+600
New +$5.76K ﹤0.01% 306

Other funds holding DFTX

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EMFO LLC's DFTX Position: Q2 2024 in Review

EMFO LLC held its Definium Therapeutics (DFTX) position steady in Q2 2024 at 300 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #260.

EMFO LLC first reported a position in DFTX in Q3 2022 and has held it in 8 quarters since. The position peaked at $2.82K in Q1 2024. 151 funds tracked by Wall St. Rank hold DFTX as of Q2 2024.

  • EMFO LLC held 300 shares of Definium Therapeutics worth $2.16K as of Q2 2024.
  • EMFO LLC left its Definium Therapeutics share count unchanged in Q2 2024.
  • Definium Therapeutics made up ﹤0.01% of EMFO LLC's portfolio in Q2 2024, its #260 holding.
  • EMFO LLC first reported a position in Definium Therapeutics in Q3 2022 and has held it in 8 quarters since.
  • EMFO LLC's Definium Therapeutics position peaked at $2.82K in Q1 2024.
  • 151 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.